Sfoglia per Autore
Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy
2009-01-01 Molinaro, Eleonora; Viola, David; Passannanti, P; Agate, Laura; Lippi, F; Ceccarelli, C; Pinchera, Aldo; Elisei, Rossella
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
2009-01-01 Elisei, Rossella; Schlumberger, M; Driedger, A; Reiners, C; Kloos, Rt; Sherman, Si; Haugen, B; Corone, C; Molinaro, Eleonora; Grasso, Lucia; Leboulleux, S; Rachinsky, I; Luster, M; Lassmann, M; Busaidy, Nl; Wahl, Rl; Pacini, F; Cho, Sy; Magner, J; Pinchera, Aldo; Ladenson, P. W.
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy
2009-01-01 Miccoli, Paolo; Pinchera, Aldo; Materazzi, Gabriele; Biagini, Agnese; Berti, Piero; Faviana, Pinuccia; Molinaro, Eleonora; Viola, David; Elisei, Rossella
Ablazione del residuo tiroideo post chirurgico con rhTSH e 30 mCi.
2010-01-01 Elisei, Rossella; Molinaro, Eleonora; Pinchera, Aldo
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
2010-01-01 Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Masserini, Lucio; Ceccarelli, C; Lippi, F; Grasso, Lucia; Basolo, Fulvio; Bevilacqua, Generoso; Miccoli, Paolo; Di Coscio, G; Vitti, Paolo; Pacini, F; Pinchera, Aldo
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study.
2011-01-01 Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Romei, C.; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
2011-01-01 Romei, Cristina; Cosci, Barbara; Renzini, G.; Bottici, Valeria; Molinaro, Eleonora; Agate, Laura; Passannanti, PAOLO FRANCESCO; Viola, David; Biagini, Agnese; Basolo, Fulvio; Ugolini, C.; Materazzi, Gabriele; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study
2012-01-01 Elisei, Rossella; Viola, David; Torregrossa, L; Giannini, Riccardo; Romei, Cristina; Ugolini, C; Molinaro, Eleonora; Agate, Laura; Biagini, Agnese; Lupi, C; Valerio, Laura; Materazzi, Gabriele; Miccoli, Paolo; Piaggi, Paolo; Pinchera, Aldo; Vitti, Paolo; Basolo, Fulvio
The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 Years experience at one single center
2012-01-01 Elisei, Rossella; Romei, Cristina; Renzini, Giulia; Bottici, Valeria; Cosci, Barbara; Molinaro, Eleonora; Agate, Laura; Cappagli, Virginia; Miccoli, Paolo; Berti, Piero; Faviana, Pinuccia; Ugolini, Clara; Basolo, Fulvio; Vitti, Paolo; Pinchera, Aldo
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study.
2012-01-01 Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella
Single thyroid nodule
2012-01-01 Elisei, Rossella; Molinaro, Eleonora
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line
2012-01-01 Vivaldi, Agnese; Ciampi, Raffaele; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P.; Elisei, Rossella
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.
2012-01-01 Vivaldi, A; Ciampi, R; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P; Elisei, Rossella
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center.
2013-01-01 D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo
Carcinoma tiroideo e gravidanza.
2013-01-01 L., Agate; Lorusso, Loredana; Molinaro, Eleonora; Elisei, Rossella
Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico.
2013-01-01 Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F.; Brozzi, F.; Viola, David; Ceccarelli, C.; Elisei, Rossella
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
2013-01-01 Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F; Brozzi, F; Ceccarelli, C; Viola, David; Piaggi, Paolo; Vitti, Paolo; Pacini, F; Elisei, Rossella
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE
2014-01-01 Casella, F.; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina
Il carcinoma tiroideo: nuove prospettive terapeutiche.
2014-01-01 Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella
Detection of metastases from differentiated thyroid cancer by different imaging techniques (neck ultrasound, computed tomography and [18F]-FDG positron emission tomography) in patients with negative post-therapeutic 131I whole-body scan and detectable serum thyroglobulin levels.
2014-01-01 Agate, Laura; Bianchi, F; Giorgetti, A; Sbragia, P; Bottici, Valeria; Brozzi, F; Santini, P; Molinaro, Eleonora; Vitti, Paolo; Elisei, Rossella; Ceccarelli, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy | 1-gen-2009 | Molinaro, Eleonora; Viola, David; Passannanti, P; Agate, Laura; Lippi, F; Ceccarelli, C; Pinchera, Aldo; Elisei, Rossella | |
| Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal. | 1-gen-2009 | Elisei, Rossella; Schlumberger, M; Driedger, A; Reiners, C; Kloos, Rt; Sherman, Si; Haugen, B; Corone, C; Molinaro, Eleonora; Grasso, Lucia; Leboulleux, S; Rachinsky, I; Luster, M; Lassmann, M; Busaidy, Nl; Wahl, Rl; Pacini, F; Cho, Sy; Magner, J; Pinchera, Aldo; Ladenson, P. W. | |
| Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy | 1-gen-2009 | Miccoli, Paolo; Pinchera, Aldo; Materazzi, Gabriele; Biagini, Agnese; Berti, Piero; Faviana, Pinuccia; Molinaro, Eleonora; Viola, David; Elisei, Rossella | |
| Ablazione del residuo tiroideo post chirurgico con rhTSH e 30 mCi. | 1-gen-2010 | Elisei, Rossella; Molinaro, Eleonora; Pinchera, Aldo | |
| Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. | 1-gen-2010 | Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Masserini, Lucio; Ceccarelli, C; Lippi, F; Grasso, Lucia; Basolo, Fulvio; Bevilacqua, Generoso; Miccoli, Paolo; Di Coscio, G; Vitti, Paolo; Pacini, F; Pinchera, Aldo | |
| Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. | 1-gen-2011 | Viola, David; Giannini, Riccardo; Ugolini, C.; Biagini, Agnese; Romei, C.; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Elisei, Rossella | |
| RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) | 1-gen-2011 | Romei, Cristina; Cosci, Barbara; Renzini, G.; Bottici, Valeria; Molinaro, Eleonora; Agate, Laura; Passannanti, PAOLO FRANCESCO; Viola, David; Biagini, Agnese; Basolo, Fulvio; Ugolini, C.; Materazzi, Gabriele; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella | |
| The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study | 1-gen-2012 | Elisei, Rossella; Viola, David; Torregrossa, L; Giannini, Riccardo; Romei, Cristina; Ugolini, C; Molinaro, Eleonora; Agate, Laura; Biagini, Agnese; Lupi, C; Valerio, Laura; Materazzi, Gabriele; Miccoli, Paolo; Piaggi, Paolo; Pinchera, Aldo; Vitti, Paolo; Basolo, Fulvio | |
| The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 Years experience at one single center | 1-gen-2012 | Elisei, Rossella; Romei, Cristina; Renzini, Giulia; Bottici, Valeria; Cosci, Barbara; Molinaro, Eleonora; Agate, Laura; Cappagli, Virginia; Miccoli, Paolo; Berti, Piero; Faviana, Pinuccia; Ugolini, Clara; Basolo, Fulvio; Vitti, Paolo; Pinchera, Aldo | |
| BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. | 1-gen-2012 | Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella | |
| Single thyroid nodule | 1-gen-2012 | Elisei, Rossella; Molinaro, Eleonora | |
| Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line | 1-gen-2012 | Vivaldi, Agnese; Ciampi, Raffaele; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P.; Elisei, Rossella | |
| Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. | 1-gen-2012 | Vivaldi, A; Ciampi, R; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Pinchera, Aldo; Collecchi, P; Elisei, Rossella | |
| Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. | 1-gen-2013 | D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo | |
| Carcinoma tiroideo e gravidanza. | 1-gen-2013 | L., Agate; Lorusso, Loredana; Molinaro, Eleonora; Elisei, Rossella | |
| Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico. | 1-gen-2013 | Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F.; Brozzi, F.; Viola, David; Ceccarelli, C.; Elisei, Rossella | |
| Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. | 1-gen-2013 | Molinaro, Eleonora; Giani, Carlotta; Agate, Laura; Biagini, Agnese; Pieruzzi, Letizia; Bianchi, F; Brozzi, F; Ceccarelli, C; Viola, David; Piaggi, Paolo; Vitti, Paolo; Pacini, F; Elisei, Rossella | |
| CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE | 1-gen-2014 | Casella, F.; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina | |
| Il carcinoma tiroideo: nuove prospettive terapeutiche. | 1-gen-2014 | Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella | |
| Detection of metastases from differentiated thyroid cancer by different imaging techniques (neck ultrasound, computed tomography and [18F]-FDG positron emission tomography) in patients with negative post-therapeutic <sup>131</sup>I whole-body scan and detectable serum thyroglobulin levels. | 1-gen-2014 | Agate, Laura; Bianchi, F; Giorgetti, A; Sbragia, P; Bottici, Valeria; Brozzi, F; Santini, P; Molinaro, Eleonora; Vitti, Paolo; Elisei, Rossella; Ceccarelli, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile